serum neurofilament light chain levels as a biomarker in ms
Published 3 years ago • 891 plays • Length 4:48Download video MP4
Download video MP3
Similar videos
-
0:53
neurofilament light chain as a biomarker in pediatric ms
-
2:29
serum nfl: a first-in-class biomarker paving the way towards precision medicine in ms
-
1:44
serum neurofilament light chain as an early disease biomarker in attr amyloidosis
-
1:34
serum neurofilament levels are associated with health outcomes and resource use in ms
-
0:42
promising biomarkers in ms: serum nfl & gfap
-
7:00
neurofilament light chain: a mulitiple sclerosis biomarker (dr. marwa kaisey interview)
-
0:59
snfl as a prognostic biomarker of ms at an individual level
-
2:01
emerging biomarkers in ms: the value of serum nfl
-
4:19
skin innervation as a prognostic biomarker in als
-
13:52
multiplex immunoassays for profiling plasma cytokines in brain tumor subjects
-
3:33
remyelinating treatments under investigation in ms
-
4:41
interpretation of serum nfl depends on the selection of a reference population
-
4:51
the association between neurofilament light chain and non-motor pd symptoms
-
15:10
neurofilament light chain: bjorn oskarsson, m.d.
-
1:59
using biomarkers to tailor treatment options for ms
-
1:45
ms disease stage modulates the relationship between serum neurofilament light and age
-
1:58
assessing the role of measuring plasma neurofilament light levels in als
-
2:14
prognostic biomarkers in multiple sclerosis
-
0:54
retinal atrophy as a biomarker in multiple sclerosis
-
3:32
blood biomarkers of disease activity in ms
-
4:21
moving towards precision medicine in ms with snfl
-
3:26
nfl to monitor treatment effects in ms